IGF-DES 0.1MG
IGF-DES (Insulin-like Growth Factor Desamino-D-Arg6)-0.1MG is a synthetic peptide derived from the insulin-like growth factor (IGF-I) sequence, specifically engineered for research applications. This compound is designed to study its potential effects on biological processes at the molecular and cellular level, without therapeutic intent.
Research Context
IGF-I and its variants are well-studied growth factors involved in cellular proliferation, differentiation, and survival. IGF-DES is a synthetic analog of IGF-I that has been modified to enhance stability and specificity for receptor binding, making it valuable in experimental settings. Research involving IGF-DES often explores its role in signaling pathways, aging processes, and tissue regeneration, particularly in in vitro and animal models.
Research Overview
IGF-DES has been utilized in preclinical studies to investigate its impact on various physiological and pathological conditions. Its modifications make it a useful tool for examining downstream signaling mechanisms, such as the PI3K/AKT pathway, which are implicated in growth, metabolism, and disease progression. Due to its structural similarities to IGF-I, IGF-DES can serve as a selective probe to study IGF receptor-mediated effects without the potential complications associated with endogenous IGF-I.
Key Research Focus Areas
- Molecular Signaling Studies: Investigation of IGF receptor signaling pathways, including the activation and regulation of downstream kinases (e.g., AKT, MAPK).
- Cellular Proliferation and Differentiation: Examination of IGF-DES effects on cell cycle progression, apoptosis, and tissue-specific differentiation in experimental models.
- Biological Aging and Regeneration: Exploration of potential anti-aging mechanisms through studies on cellular senescence, stem cell activity, and tissue repair in animal models.
- Neuroprotection and Neurodegeneration: Research into the effects of IGF-DES on neuronal survival, synaptic plasticity, and disease models such as Alzheimer’s or Parkinson’s disease.
- Metabolic and Endocrine Research: Investigation of IGF-DES influence on glucose metabolism, insulin sensitivity, and endocrine function in controlled experimental settings.
Important Notes on Use
IGF-DES 0.1MG is intended solely for research purposes and must be handled in accordance with institutional guidelines for peptide and biochemical research materials. Users should be trained in proper laboratory techniques, including sterile handling, storage conditions, and disposal procedures to ensure accuracy and safety.
| Safety Considerations | Research Compliance |
|---|---|
| Always follow local regulations for the handling of research chemicals, including restrictions on storage, transport, and documentation. | Ensure compliance with ethical standards and protocols for animal or cell-based experiments to maintain scientific integrity. |
| Limit exposure to potential contaminants or impurities, as research outcomes may be influenced by purity and formulation stability. | Maintain detailed records of all experimental procedures and results for reproducibility and accountability. |
For research use only. Not for human or animal consumption.
Reviews
There are no reviews yet.